Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    whitepaper
    From innovation to implementation: Navigating neurologic monoclonal antibody development

    Strategies for clinical readiness on day one

    thumbnail
    Making sense of the rapidly changing biosimilars landscape

    Strategies for adapting and achieving optimal market access

    thumbnail
    Building a comparative evidence base using network meta-analysis

    Methods, implementation and reporting

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media hub
    oligonucleotides
    Insights into first-in-human study design of oligonucleotides

    27 May 2026. Register now.

    Oncology whitepaper web assets
    ASCO 2026

    29 May - 2 June 2026, Booth #35093

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Healthy participants Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. Investigators
  3. Transparency - Loi Bertrand Legislation

Transparency - Loi Bertrand Legislation

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

La collaboration d’ICON avec les promoteurs, les médecins et professionnels de santé, prend différentes formes qui ont toutes un but commun : aider à développer des médicaments pour sauver des vies et améliorer la qualité de la vie des patients. ICON reconnait, le besoin d’avoir des relations ouvertes et transparentes avec tous ses intervenants. ICON est aussi tenu de respecter ses obligations légales relatives à la transparence ou à la publication énoncée dans les lois applicables.
 
Le gouvernement français a publié le mercredi 22 mai 2013 le décret relatif à la transparence (n°2013-414), qui précise les obligations légales de la loi Bertrand n° 2011-2012 du 29 Décembre 2011. L’article L.1453-1 du code de la santé publique impose une obligation de transparence pour les entreprises qui produisent ou commercialisent des produits de santé ou les entreprises qui assurent des services associées à ces produits dont ICON fait partie.
 

In this section
In this section
  • Company history
  • ICON at a glance
  • Patients
  • Healthy participants
  • ICON in Asia Pacific
    • Japan
    • India
    • China
  • Investigators
    • Clinical Study Investigators
    • Early Phase
    • Investigator Site Resource Centre
      • Commercial invoices – UK clinical trial sites shipping to ICON Dublin
      • FAQs
      • Holiday Schedule
      • Lab certificates
      • Packaging instructions
      • Site training
      • Track Shipment
      • iSite
      • LabView360
    • Register
      • Early Phase
    • Transparency - Loi Bertrand Legislation
      • Contact
      • La Réglementation
      • Les données de transparence
  • ICON in Latin America
  • Jobs & Careers
  • Investors
  • Leadership
    • Board of Directors
  • Quality
  • Suppliers
  • Environmental, Social and Governance
    • Environment
    • Governance
    • Social

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media
Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
  • Social media hub
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies